Despite patients sharing a usual interstitial pneumonia (UIP) pattern on lung CT scans, patients with connective tissue disease-related interstitial lung disease (CTD-ILD) demonstrated a slower ...

Advanced imaging, like 4D-flow CMR, aids in understanding PA remodeling in different PH subtypes, offering non-invasive differentiation. PAH patients exhibit distinct PA flow characteristics, ...

IPF is a chronic, progressive lung disease marked by lung tissue thickening and scarring, leading to reduced lung function. It is a specific type of interstitial lung disease, which includes various ...

Older age, male sex, and seropositivity are linked to a higher risk for rheumatoid arthritis– interstitial lung disease (RA-ILD) with a usual interstitial pneumonia (UIP) pattern, while only ...

Childhood interstitial lung disease (chILD) comprises a heterogeneous group of rare, chronic pulmonary disorders that affect the lung parenchyma. These conditions are characterised by complex ...

Three independent cohorts of patients with lung cancer were evaluated using a variety of DNA microarray assays. Using the integrative correlations method, a subset of genes was selected, the ...

Please provide your email address to receive an email when new articles are posted on . “Patients with ILD are at an elevated risk of developing lung cancer across all subtypes, especially rare and ...

Big-picture patterns of DNA packaging, gene activation and mutations could hold the information needed to develop a blood-based biopsy for small cell lung cancer patients, according to new work ...

Lung cancer is the leading cause of cancer-related mortality worldwide, with significant heterogeneity among its major histological subtypes: adenocarcinoma (ADC), squamous cell carcinoma (SCC), and ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...